Lupus Erythematosus, Cutaneous
Information
- Disease name
- Lupus Erythematosus, Cutaneous
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02034344 | Completed | A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers | October 2013 | May 2015 | |
| NCT04493541 | Completed | Phase 1 | A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus | August 26, 2020 | April 21, 2023 |
| NCT01352988 | Completed | Phase 2 | Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus | July 2011 | February 2014 |
| NCT02927457 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects | January 13, 2017 | June 12, 2018 |
| NCT02656082 | Completed | Phase 2 | Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus | February 1, 2016 | December 31, 2017 |
| NCT01702740 | Completed | Phase 1 | A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus | March 2007 | October 2009 |
| NCT01845740 | Completed | Phase 1 | Phase Ib Study of SC Milatuzumab in SLE | January 2007 | June 2009 |
| NCT01923415 | Completed | A Non-drug Study Profiling Cutaneous Lupus | April 2013 | August 2014 | |
| NCT05879718 | Recruiting | Phase 2 | A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. | July 7, 2023 | November 18, 2026 |
| NCT02428309 | Terminated | Phase 1 | Autologous Polyclonal Tregs for Lupus | August 27, 2015 | October 3, 2018 |
| NCT01559155 | Terminated | Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid | November 5, 2013 | June 9, 2015 | |
| NCT01407679 | Terminated | Phase 2 | Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus | August 2011 | April 2014 |
| NCT00420121 | Unknown status | European Society of Cutaneous Lupus Erythematosus (EUSCLE) | January 2007 | December 2019 | |
| NCT04707924 | Withdrawn | N/A | Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars | June 1, 2021 | December 1, 2022 |
| NCT00222183 | Withdrawn | N/A | Cutaneous Lupus Erythematosus and Elidel | June 2003 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008178